TrialNutrients2019

The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.

Bertha Araceli Marin-Alejandre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.